磁共振引导聚焦超声丘脑毁损术治疗特发性震颤:2年随访结果
该前瞻性研究纳入76例中重度特发性震颤患者,接受单侧MRgFUS丘脑毁损术,67例完成2年开放扩展期随访。结果显示手部震颤评分较基线改善55%(6个月)、53%(1年)和56%(2年),残疾评分改善64%(6个月)并持续至2年,无新的迟发并发症。
要点
- MRgFUS丘脑毁损术对特发性震颤的疗效在2年内稳定维持。
- 最常见不良事件为感觉异常和步态障碍,随访期间未加重。
- 2年随访未出现新的迟发并发症。
核心结论
- MRgFUS丘脑毁损术治疗特发性震颤的震颤抑制在2年时稳定维持。
- 治疗后未出现潜伏或迟发并发症。
研究设计与样本
- 前瞻性随机研究,纳入76例中重度特发性震颤且至少两种药物治疗无效的患者,接受单侧MRgFUS丘脑毁损术。
- 67例进入开放扩展期并随访2年,9例排除(如3例改用脑深部电刺激,1例热毁损不充分)。
主要发现
- 手部震颤评分基线为19.8±4.9(76例),6个月改善55%至8.6±4.5(75例)。
- 震颤评分改善1年时为53%(8.9±4.8,70例),2年时为56%(8.8±5.0,67例)。
- 残疾评分基线为16.4±4.5(76例),6个月改善64%至5.4±4.7(75例)。
- 残疾评分1年时为5.4±5.3(70例),2年时为6.5±5.0(67例)。
- 1年时感觉异常和步态障碍各见于10例患者,另有5例出现其他神经不良事件,随访期间未加重,其中2例缓解。
临床怎么用
- 对于药物难治的中重度特发性震颤患者,MRgFUS丘脑毁损术可作为维持2年疗效的选择。
局限性
- 开放扩展期随访,部分患者排除(如改用脑深部电刺激或热毁损不充分),可能影响结果解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Magnetic resonance guided focused ultrasound (MRgFUS) has recently been investigated as a new treatment modality for essential tremor (ET), but the durability of the procedure has not yet been evaluated. This study reports results at a 2- year follow-up after MRgFUS thalamotomy for ET. METHODS: A total of 76 patients with moderate-to-severe ET, who had not responded to at least two trials of medical therapy, were enrolled in the original randomized study of unilateral thalamotomy and evaluated using the clinical rating scale for tremor. Sixty-seven of the patients continued in the open-label extension phase of the study with monitoring for 2 years. Nine patients were excluded by 2 years, for example, because of alternative therapy such as deep brain stimulation (n = 3) or inadequate thermal lesioning (n = 1). However, all patients in each follow-up period were analyzed. RESULTS: Mean hand tremor score at baseline (19.8 ± 4.9; 76 patients) improved by 55% at 6 months (8.6 ± 4.5; 75 patients). The improvement in tremor score from baseline was durable at 1 year (53%; 8.9 ± 4.8; 70 patients) and at 2 years (56%; 8.8 ± 5.0; 67 patients). Similarly, the disability score at baseline (16.4 ± 4.5; 76 patients) improved by 64% at 6 months (5.4 ± 4.7; 75 patients). This improvement was also sustained at 1 year (5.4 ± 5.3; 70 patients) and at 2 years (6.5 ± 5.0; 67 patients). Paresthesias and gait disturbances were the most common adverse effects at 1 year-each observed in 10 patients with an additional 5 patients experiencing neurological adverse effects. None of the adverse events worsened over the period of follow-up, and 2 of these resolved. There were no new delayed complications at 2 years. INTERPRETATION: Tremor suppression after MRgFUS thalamotomy for ET is stably maintained at 2 years. Latent or delayed complications do not develop after treatment. Ann Neurol 2018;83:107-114.
引用
- Chang JW, Park CK, Lipsman N, et al. A prospective trial of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor: Results at the 2-year follow-up. Ann Neurol. 2018. PMID: 29265546. doi:10.1002/ana.25126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。